...
首页> 外文期刊>Gynecologic Oncology: An International Journal >The Moore Criteria: Applicability in a diverse, non-trial, recurrent cervical cancer population
【24h】

The Moore Criteria: Applicability in a diverse, non-trial, recurrent cervical cancer population

机译:摩尔标准:适用于多种,非试验性宫颈癌人口

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective. The Moore Criteria is a prognostic index for recurrent or metastatic cervical cancer based on five factors. The criteria were developed retrospectively and validated prospectively in clinical trial populations receiving systemic chemotherapy (C). Our objective was to evaluate the prognostic value of the Moore Criteria in a largely minority, non-trial population at first recurrence.
机译:客观的。 摩尔标准是基于五个因素的复发性或转移性宫颈癌的预后指标。 在接受全身化疗(C)的临床试验群体中临床试验患有标准并验证标准。 我们的目标是评估摩尔标准的预后价值在主要少数群体,非审判群体首次复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号